Academic Journal

Targeting soluble PD-1 alleviates peritoneal fibrosis by modulating PD-L1 recycling and mesothelial-mesenchymal transition.

Λεπτομέρειες βιβλιογραφικής εγγραφής
Τίτλος: Targeting soluble PD-1 alleviates peritoneal fibrosis by modulating PD-L1 recycling and mesothelial-mesenchymal transition.
Συγγραφείς: Peng H; Department of Nephrology, Xijing Hospital, The Fourth Military Medical University, No.127, Changle West Road, Xi'an, 710032, China., Feng S; Department of Nephrology, Xijing Hospital, The Fourth Military Medical University, No.127, Changle West Road, Xi'an, 710032, China., Xiao K; Department of Nephrology, Xijing Hospital, The Fourth Military Medical University, No.127, Changle West Road, Xi'an, 710032, China; Grade 2021 Clinical Medicine (Five-Year Program), Basic Medical College, The Fourth Military Medical University, Xi'an, China., Li J; Department of Nephrology, Xijing Hospital, The Fourth Military Medical University, No.127, Changle West Road, Xi'an, 710032, China., Xu X; Department of Nephrology, Xijing Hospital, The Fourth Military Medical University, No.127, Changle West Road, Xi'an, 710032, China., Wu M; Department of Nephrology, Xijing Hospital, The Fourth Military Medical University, No.127, Changle West Road, Xi'an, 710032, China., Zhao F; Department of Nephrology, Xijing Hospital, The Fourth Military Medical University, No.127, Changle West Road, Xi'an, 710032, China., Zha Y; Department of Nephrology, Xijing Hospital, The Fourth Military Medical University, No.127, Changle West Road, Xi'an, 710032, China., Lu R; Department of Nephrology, Xijing Hospital, The Fourth Military Medical University, No.127, Changle West Road, Xi'an, 710032, China., Chen Y; Department of Nephrology, Xijing Hospital, The Fourth Military Medical University, No.127, Changle West Road, Xi'an, 710032, China., Yang G; Department of Biochemistry and Molecular Biology, The Fourth Military Medical University, Xi'an, China. Electronic address: yanggd@fmmu.edu.cn., Zhao Y; Department of Medical Microbiology and parasitology, The Fourth Military Medical University, Xi'an, China. Electronic address: zhaoya@fmmu.edu.cn., Zhang Y; Department of Nephrology, Xijing Hospital, The Fourth Military Medical University, No.127, Changle West Road, Xi'an, 710032, China. Electronic address: zhangyuting_51@163.com., He L; Department of Nephrology, Xijing Hospital, The Fourth Military Medical University, No.127, Changle West Road, Xi'an, 710032, China. Electronic address: helijie@fmmu.edu.cn.
Πηγή: Translational research : the journal of laboratory and clinical medicine [Transl Res] 2026 Oct; Vol. 296, pp. 70-82. Date of Electronic Publication: 2026 Jul 14.
Τύπος έκδοσης: Journal Article
Γλώσσα: English
Στοιχεία περιοδικού: Publisher: Elsevier Country of Publication: United States NLM ID: 101280339 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1878-1810 (Electronic) Linking ISSN: 18781810 NLM ISO Abbreviation: Transl Res Subsets: MEDLINE
Imprint Name(s): Original Publication: New York, N.Y. : Elsevier, [2006]-
Ιατρικοί όροι (MeSH): Peritoneal Fibrosis*/pathology , Peritoneal Fibrosis*/metabolism , Peritoneal Fibrosis*/blood , B7-H1 Antigen*/metabolism , Programmed Cell Death 1 Receptor*/blood , Programmed Cell Death 1 Receptor*/metabolism , Epithelial-Mesenchymal Transition*, Exosomes/metabolism ; Animals ; Humans ; Mice ; Male ; Mice, Inbred C57BL ; Peritoneal Dialysis ; Female
Περίληψη: Background: Peritoneal fibrosis (PF) is a major cause of technique failure in long-term peritoneal dialysis (PD) patients, driven by a chronic microinflammatory state. While T-cell activation is implicated, the role of soluble programmed death-1 (sPD-1), primarily derived from activated T cells, in PF pathogenesis remains elusive.
Methods: We initially analyzed serum sPD-1 levels in PD patients and employed a mice PF model induced by high-glucose dialysate and lipopolysaccharide (LPS). The functional impact of sPD-1 on the progression of PF was assessed through the administration of a PD-L1 fusion protein, or engineered exosomes designed to adsorb sPD-1.
Results: Serum sPD-1 levels were significantly elevated in long-term PD patients and were positively correlated with dialysis duration and markers of fibrosis, but inversely correlating with peritoneal function. In mice, exogenous sPD-1 exacerbated PF, whereas blockade with a PD-L1 fusion protein or sPD-1-adsorbing engineered exosomes markedly attenuated fibrosis, reduced T-cell infiltration, and preserved peritoneal function. Mechanistically, sPD-1 bound to PD-L1 on PMCs, triggering clathrin-mediated endocytosis. This interaction diverted PD-L1 from the lysosomal degradation pathway towards the Rab11-positive recycling endosome pathway, resulting in sustained upregulation of surface PD-L1 expression. This aberrant PD-L1 recycling activated pro-fibrotic signaling, culminating in mesothelial-to-mesenchymal transition (MMT).
Conclusion: sPD-1 is a pivotal mediator linking peritoneal microinflammation to fibrosis by modulating the endocytic fate of PD-L1 in mesothelial cells. Targeting sPD-1, particularly using engineered exosomes or a PD-L1 fusion protein, represents a promising therapeutic strategy for preventing and treating peritoneal fibrosis.
(Copyright © 2026 The Authors. Published by Elsevier Inc. All rights reserved.)
Contributed Indexing: Keywords: Endosomes; Mesothelial-mesenchymal transition; Peritoneal dialysis; Peritoneal fibrosis; Targeted therapy; sPD-1
Substance Nomenclature: 0 (B7-H1 Antigen)
0 (Programmed Cell Death 1 Receptor)
0 (CD274 protein, human)
Entry Date(s): Date Created: 20260714 Date Completed: 20260829 Latest Revision: 20260829
Update Code: 20260830
DOI: 10.1016/j.trsl.2026.07.005
PMID: 42448218
Βάση Δεδομένων: MEDLINE